Saturday, July 5, 2025 7/5/2025

Identifying new drivers of ovarian cancer from the non-coding genome by converging germline risk variants and somatic mutations

Award Number: K99CA256519
ORGANIZATION: NATIONAL CANCER INSTITUTE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: TRAINING/TRAINEESHIP
PERIOD OF PERFORMANCE START DATE: 01/01/2021
PERIOD OF PERFORMANCE END DATE: 06/30/2023

Group Awards By:

View Award Description

Identifying new drivers of ovarian cancer from the non-coding genome by converging germline risk variants and somatic mutations - PROJECT SUMMARY/ABSTRACT The goal of the proposed research training program is to provide tailored additional training to facilitate successful career development throughout the completion of postdoctoral fellowship and the transition to independent tenure track professor. The key elements of this plan are: Candidate: I have considerable research experience in developing and applying computational models to understand complex biological systems. The training component of this proposal will focus on acquisition of knowledge in cancer genetics and genomics, integrative computational methodologies, and next-generation sequencing technologies. Additionally, I will receive training in laboratory management, networking and collaborations, and grant submissions. This well-rounded training plan will accelerate my goals of being an independent researcher and developing computational models to better understand cancer biology. Environment: The training environment at Cedars-Sinai Medical Center fosters productivity and collaboration with world class researchers in clinical and basic biomedical science. I have assembled an advisory committee with esteemed experts in the areas of epigenomics, genetics, data science and cancer biology to ensure my success in this training program and to guide me through the successful acquisition of a tenure track faculty position. These include my mentor Dr. Simon Gayther and four advisors, Dr. Benjamin Berman and Dr. Shelly Lu from Cedars-Sinai, and Dr. Bogdan Pasaniuc, and Dr. Paul Boutros from University of California, Los Angeles. Research: A fundamental goal of human genetics is to decipher the relationship between genotype and phenotype. Cancer is a disease comprising a heritable component that confers cancer predisposition and an acquired (somatic) component where accumulation of genetic alterations occurs during disease development. Population based genome-wide association studies (GWAS) and whole genome sequencing (WGS) analyses have identified thousands of germline risk variants and somatic non-coding mutations involved in ovarian cancer development. Often, protein-coding cancer driver genes harbor both deleterious germline risk variants and somatic mutations. This proposal hypothesizes that the same is true for non-coding cancer drivers. With the wealth of epigenomics and regulatory datasets, the goal is to identify genomic regions where there are interactions between germline and somatic variants. The specific aims are: (1) identify functional regulatory elements where non-coding germline and somatic ovarian cancer variants co-localize; (2) identify non-coding ovarian cancer drivers through multi-omics regulatory evidence by machine learning models. The proposed studies will establish systematic and quantitative models to identify ovarian cancer non-coding drivers and improve our understanding of disease etiology.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2024 ( Subtotal = -$2,374 )
2024	2022	CEDARS-SINAI MEDICAL CENTER	8700 BEVERLY BLVD	WEST HOLLYWOOD	CA	90048	LOS ANGELES	USA	Cancer Research Manpower	000	2	7/30/2024	NON-COMPETING CONTINUATION	-$2,374
														Subtotal = -$2,374

Issue Date FY: 2023 ( Subtotal = $0 )
2023	2022	CEDARS-SINAI MEDICAL CENTER	8700 BEVERLY BLVD	WEST HOLLYWOOD	CA	90048	LOS ANGELES	USA	Cancer Research Manpower	000	2	1/6/2023	NON-COMPETING CONTINUATION	$0
2023	2022	CEDARS-SINAI MEDICAL CENTER	8700 BEVERLY BLVD	WEST HOLLYWOOD	CA	90048	LOS ANGELES	USA	Cancer Research Manpower	001	2	6/19/2023	NON-COMPETING CONTINUATION	$0
														Subtotal = $0

Issue Date FY: 2022 ( Subtotal = $226,612 )
2022	2022	CEDARS-SINAI MEDICAL CENTER	8700 BEVERLY BLVD	LOS ANGELES	CA	90048	LOS ANGELES	USA	Cancer Research Manpower	000	2	12/22/2021	NON-COMPETING CONTINUATION	$172,908
2022	2022	CEDARS-SINAI MEDICAL CENTER	8700 BEVERLY BLVD	LOS ANGELES	CA	90048	LOS ANGELES	USA	Cancer Research Manpower	001	2	6/7/2022	NON-COMPETING CONTINUATION	$53,704
														Subtotal = $226,612

Issue Date FY: 2021 ( Subtotal = $173,048 )
2021	2021	CEDARS-SINAI MEDICAL CENTER	8700 BEVERLY BLVD	LOS ANGELES	CA	90048	LOS ANGELES	USA	Cancer Research Manpower	000	1	12/30/2020	NEW	$173,048
2021	2021	CEDARS-SINAI MEDICAL CENTER	8700 BEVERLY BLVD	LOS ANGELES	CA	90048	LOS ANGELES	USA	Cancer Research Manpower	001	1	1/8/2021	NEW	$0
														Subtotal = $173,048

Grand Total All Awards = $397,286

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Identifying new drivers of ovarian cancer from the non-coding genome by converging germline risk variants and somatic mutations

Award Number: K99CA256519

ORGANIZATION: NATIONAL CANCER INSTITUTE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: TRAINING/TRAINEESHIP

PERIOD OF PERFORMANCE START DATE: 01/01/2021

PERIOD OF PERFORMANCE END DATE: 06/30/2023

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer